Final results of ProGem1, the first in-human phase I/II study of NUC-1031 in patients with solid malignancies - Blagden,SP; Rizzuto,I; Stavraka,C; O'Shea,D; Suppiah,P; Patel,M; Sukumaran,A; Loyse,N; Bharwani,N; Rockall,A; Gabra,H; El-Bahrawy,M; et al. (American Society of Clinical Oncology, 2015)